About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 702 record(s)
Req # A-2021-001639
Adverse Drug Reaction (ADR) for LEVOMEPROMAZINE MALEATE. Report number: E2B_04128374.Organization: Health Canada
March 2022
Req # A-2021-001645
Adverse Drug Reaction (ADR) for TRIAMCINOLONE ACETONIDE. Report number: E2B_04117611.Organization: Health Canada
March 2022
Req # A-2021-001647
Adverse Drug Reaction (ADR) for DESOXIMETASONE. Report Number: E2B_03766482.Organization: Health Canada
March 2022
Req # A-2021-001649
Adverse Drug Reactions (ADRs) for METOLAZONE. Report Numbers: 000952354, E2B_04308431.Organization: Health Canada
March 2022
Req # A-2021-001656
Adverse Drug Reaction (ADRs) for RANITIDINE HYDROCHLORIDE. Report Numbers: E2B_04589242, E2B_01758072.Organization: Health Canada
March 2022
Req # A-2021-001657
Adverse Drug Reaction (ADRs) for HYOSCINE BUTYLBROMIDE. Report Numbers: E2B_04368606, E2B_00344184.Organization: Health Canada
March 2022
Req # A-2021-001659
Adverse Drug Reaction (ADRs) for LEFLUNOMIDE. Report Numbers: 957811, 958644, 958264, 963790, 963510, 960394, 963351, 962461, 961127, 962757, 964757, 966667, 964855, 963775, 965544, E2B_04459278, 964636, E2B_04361183, E2B_04456490, 968545.Organization: Health Canada
March 2022
Req # A-2021-001668
Adverse Drug Reaction (ADR) for IPRATROPIUM BROMIDE. Report Number: E2B_04602334.Organization: Health Canada
March 2022
Req # A-2021-001670
Adverse Drug Reaction (ADR) for ZOPICLONE. Report Number: 960750.Organization: Health Canada
March 2022
Req # A-2021-001673
Adverse Drug Reaction (ADRs) for LEFLUNOMIDE. Report Numbers: 000969509, 000970004, 000968074, 000970614, E2B_04501996, E2B_04512800, E2B_04516063, E2B_04563304, 000968325, E2B_04577418, 000968379, E2B_04585759, E2B_04589548, 000968733, 000970366,…Organization: Health Canada
March 2022